Wedbush Downgrades Dova Pharmaceuticals Inc (DOVA) to Neutral on Pending Acquisition
Tweet Send to a Friend
Wedbush analyst Laura Chico downgraded Dova Pharmaceuticals Inc (NASDAQ: DOVA) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
